|
Market Closed -
Euronext Paris
11:55:00 2026-09-04 am EDT
|
5-day change | 1st Jan Change | ||
| 76.26 EUR | -0.01% |
|
-1.28% | -7.81% |
| Sep. 02 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| Sep. 02 | Sanofi : Gets a Buy rating from Deutsche Bank | ZD |
| Market Cap | 91.36B 106B 85.96B 78.53B 147B 10,025B 147B 1,016B 394B 5,143B 399B 390B 16,570B | P/E 2026 * |
12.1x | P/E 2027 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 103B 119B 96.74B 88.37B 165B 11,282B 166B 1,143B 444B 5,788B 449B 439B 18,647B | EV / Sales 2026 * |
2.16x | EV / Sales 2027 * | 1.96x |
| Free-Float |
88.34% | Yield 2026 * |
5.58% | Yield 2027 * | 5.9% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
Tradegate
| SNW | Real-time | |
|
Xetra
| SNW | Delayed | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
CBOE
| 0O59 | Real-time | |
|
Boerse Muenchen
| SNW | Real-time | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
OTC Markets
| SNYNF | Delayed | |
|
Mexican S.E.
| SAN1 N | End-of-day quote | |
|
London S.E.
| 0O59 | Delayed | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Swiss Exchange
| SAN | Delayed |
Last Transcript : Sanofi
| 1 day | -0.01% | ||
| 1 week | -1.28% | ||
| Current month | -0.72% | ||
| 1 month | +2.51% | ||
| 3 months | -0.24% | ||
| 6 months | -3.75% | ||
| Current year | -7.81% |
| 1 week | 75.9 |  | 78.15 |
| 1 month | 73.63 | | 79.36 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 8/20/26 | Buy | Executive/Senior Manager | 840 | 0.0001% | ||
| 8/20/26 | Buy | Executive/Senior Manager | 1,422 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | -1.28% | -3.42% | -22.21% | 106B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| Average | -0.89% | +0.86% | +25.13% | +43.80% | 378.45B | |
| Weighted average by Cap. | -1.07% | +0.50% | +35.50% | +63.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.66B 55.38B 44.84B 40.96B 76.62B 5,229B 76.83B 530B 206B 2,683B 208B 203B 8,643B | 50.76B 58.98B 47.75B 43.62B 81.61B 5,569B 81.83B 564B 219B 2,857B 221B 217B 9,205B |
| Net income | 7.63B 8.87B 7.18B 6.56B 12.27B 837B 12.3B 84.82B 32.91B 429B 33.29B 32.57B 1,384B | 8.93B 10.38B 8.4B 7.68B 14.36B 980B 14.4B 99.28B 38.53B 503B 38.97B 38.12B 1,619B |
| Net Debt | 11.46B 13.31B 10.78B 9.85B 18.42B 1,257B 18.47B 127B 49.43B 645B 50B 48.91B 2,078B | 8.3B 9.65B 7.81B 7.14B 13.35B 911B 13.39B 92.32B 35.82B 467B 36.24B 35.45B 1,506B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | €76.26 | -0.01% | 1,490,914 |
| 26-09-03 | €76.27 | -1.15% | 1,808,704 |
| 26-09-02 | €77.16 | +0.39% | 1,244,986 |
| 26-09-01 | €76.86 | +0.07% | 1,718,967 |
| 26-08-31 | €76.81 | -0.57% | 2,863,251 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
